Target intelligence / Profile preview

Tumor necrosis factor receptor superfamily member 10A (DR4) and Tumor necrosis factor receptor superfamily member 10B (DR5) (DR4 and DR5)

Target
DR4 and DR5
Molecular classification
Receptor, Tumor necrosis factor receptor superfamily
01

Overview

Tumor necrosis factor receptor superfamily member 10A (DR4) and 10B (DR5) are transmembrane proteins that mediate the extrinsic pathway of apoptosis (Source: UniProt O00220, O14763). These receptors are activated upon binding to the TNF-related apoptosis-inducing ligand (TRAIL), which is primarily expressed by immune cells like natural killer cells and T cells. Binding induces receptor trimerization and the assembly of the death-inducing signaling complex (DISC), involving the recruitment of the adapter protein FADD and pro-caspase-8 (Source: PMID: 29330110). This molecular assembly triggers a proteolytic cascade of caspases that ultimately results in programmed cell death. Because DR4 and DR5 are often upregulated in various malignant cells while being minimally expressed or decoyed in healthy tissues, they are significant targets for selective cancer therapies. Therapeutic strategies have included recombinant human TRAIL variants and agonistic monoclonal antibodies designed to mimic the ligand's pro-apoptotic action. Despite promising preclinical data, clinical success has been hampered by the short half-life of first-generation agents and the presence of intrinsic or acquired resistance in many tumors. Recent drug development efforts focus on next-generation multivalent agonists and combination regimens to enhance signaling intensity and overcome resistance (Source: PMID: 31434151). Notable safety concerns include potential hepatotoxicity, which was observed with certain high-potency multivalent DR5 agonists in early-phase trials.

Other names
TRAIL-R1TRAIL-R2Death receptor 4Death receptor 5TNFRSF10ATNFRSF10BCD261CD262APO2KILLERTRICK2
02

Mechanism of action

Agonism of DR4 and DR5 induces receptor trimerization and the subsequent assembly of the death-inducing signaling complex (DISC), which recruits FADD and pro-caspase-8 to initiate the caspase cascade and trigger programmed cell death (Source: PMID: 31434151).

03

Biological functions

ApoptosisSignal transductionCell deathExtrinsic apoptotic pathway
04

Disease associations

Cancer
05

Safety considerations

Hepatotoxicity (observed with multivalent agonists like TAS266)Intrinsic and acquired tumor resistanceShort serum half-life of recombinant ligandsLimited clinical efficacy as monotherapy
06

Interacting drugs

Dulanermin

10 more in the full profile.

07

Biomarkers

DR4 surface expressionDR5 surface expressionCaspase-8 expression levelsFADD expression levelsc-FLIP expression (resistance marker)GALNT14 expression (O-glycosylation marker)

Beyond the preview

Go deeper on Tumor necrosis factor receptor superfamily member 10A (DR4) and Tumor necrosis factor receptor superfamily member 10B (DR5) (DR4 and DR5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor necrosis factor receptor superfamily member 10A (DR4) and Tumor necrosis factor receptor superfamily member 10B (DR5) (DR4 and DR5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call